SCD and diabetes mellitus: In agreement with our findings and previously reported beneficial effects of SCD1 in type 2 diabetes mellitus21,34, thiazolidinedione treatment led to increased SCD1 expression in AT of patients with type 2 diabetes mellitus together with improved TG esterification and IS20.